人类F-ATP合成酶作为药物标
Christoph Gerle1, Chimari Jiko2, Atsuki Nakano3
1Life Science Research Infrastructure Group, RIKEN SPring-8 Center, Kouto, 1-1-1, Sayo, Hyogo, Japan.
Pharmacological research
|September 20, 2024
概括
人类F-ATP合成酶对细胞能量至关重要,具有治疗潜力. 本综述探讨了其功能,并确定了开发新药治疗人类疾病的结构性目标.
科学领域:
- 生物化学和分子生物学
- 药理学和药物开发领域
背景情况:
- 人类F-ATP合成酶是细胞能量生产中的关键酶,由于实际和概念上的挑战,它仍然是一个难以捉摸的治疗目标.
- 尽管进行了数十年的研究,但针对人类F-ATP合成酶的有效药物干预尚未实现.
研究的目的:
- 审查人类F-ATP合成酶的主要功能,包括质子动力/ATP相互转换,膜曲和线粒体透性过渡.
- 探索针对这些功能性的药物干预的潜力.
- 讨论设计针对人类F-ATP合成酶有效药物的技术要求.
主要方法:
- 对人类F-ATP合成酶功能及其治疗潜力的文献综述.
- 对针对F-ATP合成酶的药物设计技术要求的分析.
- 以胃质子抑制剂的基于结构的开发为模型的案例研究.
- 检查人类F-ATP合成酶的特定结构区域作为潜在的药物开发地点.
主要成果:
- 人类F-ATP合成酶表现出多种功能 (质子驱动力/ATP相互转换,膜曲,线粒体透性过渡) 具有制药潜力.
- 基于结构的药物设计,以胃质子抑制剂为例,为向F-ATP合成酶提供了一种可行的方法.
- 人类F-ATP合成酶的四个不同的结构区域被确定为基于结构的药物开发的有希望的地点.
结论:
- 人类F-ATP合成酶具有显著的治疗前景,其多种功能为药物干预提供了多种途径.
- 通过基于结构的药物设计克服现有的障碍是释放人类F-ATP合成酶治疗潜力的关键.
- 针对特定的结构区域,为开发针对人类疾病的新疗法提供了一个可行的战略.
相关概念视频
ATP Synthase: Mechanism
14.0K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.0K
ATP Synthase: Structure
12.0K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
12.0K
ATP Driven Pumps I: An Overview
8.0K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
8.0K
ATP Driven Pumps III: V-type Pumps
3.6K
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
3.6K
The ADP/ATP Carrier Protein
3.2K
ADP/ATP carrier or AAC protein is the most abundant carrier protein in the inner mitochondrial membrane. It transports large quantities of ADP and ATP, equivalent to the average human body weight, every day. Among other transporters, ACC protein is one of the best-studied members of the mitochondrial carrier protein family. The ADP/ATP carrier protein comprises two transmembrane helices connected to a loop and a single alpha-helix on the matrix side. It switches between two conformational...
3.2K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K


